Total Payments
$44,158
2024 Payments
$143.92
Companies
34
Transactions
393
Medicare Patients
1,794
Medicare Billing
$140,976

Payment Breakdown by Category

Other$27,590 (62.5%)
Food & Beverage$7,301 (16.5%)
Consulting$5,300 (12.0%)
Travel$3,648 (8.3%)
Education$285.20 (0.6%)
Gifts$34.96 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $27,590 16 62.5%
Food and Beverage $7,301 301 16.5%
Consulting Fee $5,300 6 12.0%
Travel and Lodging $3,648 28 8.3%
Education $285.20 4 0.6%
Gift $34.96 38 0.1%

Top Paying Companies

Company Total Records Latest Year
Galderma Laboratories, L.P. $35,258 119 $0 (2024)
Exeltis, USA Inc. $4,630 12 $0 (2018)
ABBVIE INC. $740.05 34 $0 (2024)
PFIZER INC. $631.54 60 $0 (2024)
Novum Pharma, LLC $410.37 43 $0 (2018)
Janssen Biotech, Inc. $290.80 10 $0 (2019)
Novartis Pharmaceuticals Corporation $243.26 13 $0 (2023)
GENZYME CORPORATION $207.34 10 $0 (2024)
Encore Dermatology Inc. $202.68 16 $0 (2018)
Regeneron Healthcare Solutions, Inc. $188.58 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $143.92 7 Regeneron Healthcare Solutions, Inc. ($35.00)
2023 $119.13 6 ABBVIE INC. ($28.98)
2022 $37.43 2 ABBVIE INC. ($19.61)
2021 $108.13 7 UCB, Inc. ($24.40)
2020 $65.04 5 AbbVie Inc. ($25.98)
2019 $7,544 63 Galderma Laboratories, L.P. ($6,853)
2018 $29,259 164 Galderma Laboratories, L.P. ($27,816)
2017 $6,882 139 Exeltis, USA Inc. ($4,406)

All Payment Transactions

393 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
12/11/2024 PFIZER INC. CIBINQO (Drug), LITFULO Food and Beverage In-kind items and services $14.17 General
Category: Inflammation & Immunology
12/03/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $24.91 General
Category: IMMUNOLOGY
08/22/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $35.00 General
Category: ONCOLOGY
06/21/2024 PFIZER INC. CIBINQO (Drug) Education In-kind items and services $15.27 General
Category: Inflammation & Immunology
04/25/2024 Galderma Laboratories, L.P. DYSPORT (Biological) Food and Beverage In-kind items and services $16.08 General
04/25/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $16.04 General
Category: Immunology
03/26/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Winlevi (Drug), Absorica LD Food and Beverage In-kind items and services $22.45 General
Category: Dermatology
09/27/2023 Galderma Laboratories, L.P. DYSPORT (Biological) Food and Beverage In-kind items and services $14.20 General
07/13/2023 GENZYME CORPORATION DUPIXENT (Biological), DUPIXENT Food and Beverage In-kind items and services $23.88 General
Category: Immunology
07/06/2023 Novartis Pharmaceuticals Corporation COSENTYX (Drug) Food and Beverage In-kind items and services $26.15 General
Category: Dermatology
06/14/2023 Lilly USA, LLC TALTZ (Drug) Food and Beverage In-kind items and services $13.19 General
Category: Immunology
04/13/2023 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $28.98 General
Category: IMMUNOLOGY
03/28/2023 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $12.73 General
11/17/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $19.61 General
Category: IMMUNOLOGY
03/10/2022 Novartis Pharmaceuticals Corporation COSENTYX (Biological) Food and Beverage In-kind items and services $17.82 General
Category: IMMUNOLOGY
12/09/2021 Biofrontera Inc. AMELUZ (Drug), BF-RhodoLED, XEPI Food and Beverage Cash or cash equivalent $7.68 General
Category: DERMATOLOGY
11/19/2021 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $24.40 General
Category: Immunology
07/14/2021 Bausch & Lomb, a division of Bausch Health US, LLC INFUSE (Device) Food and Beverage In-kind items and services $18.58 General
Category: Ophthalmology
03/11/2021 Medimetriks Pharmaceuticals, Inc. Clindacin ETZ (Drug), Neo-Synalar, Tovet (emollient formulation) Food and Beverage In-kind items and services $12.14 General
Category: Dermatology
02/18/2021 Biofrontera Inc. BF-RhodoLED (Device), XEPI, AMELUZ Food and Beverage Cash or cash equivalent $16.10 General
Category: DERMATOLOGY
02/10/2021 SUN PHARMACEUTICAL INDUSTRIES INC. Ilumya (Biological) Food and Beverage In-kind items and services $16.42 General
Category: Dermatology
01/25/2021 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $12.81 General
12/10/2020 AbbVie Inc. SKYRIZI (Biological) Food and Beverage In-kind items and services $13.28 General
Category: IMMUNOLOGY
09/17/2020 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $12.12 General
Category: Immunology
09/01/2020 Medimetriks Pharmaceuticals, Inc. Clindacin ETZ (Drug), Genadur, Ketodan Food and Beverage In-kind items and services $13.28 General
Category: Dermatology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 448 794 $142,329 $35,190
2022 7 319 566 $98,343 $24,057
2021 11 545 957 $175,889 $49,087
2020 10 482 756 $133,672 $32,643
Total Patients
1,794
Total Services
3,073
Medicare Billing
$140,976
Procedure Codes
37

All Medicare Procedures & Services

37 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 119 191 $38,062 $12,223 32.1%
17110 Destruction of skin growth, 1-14 growths Office 2023 58 77 $27,878 $5,780 20.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 39 47 $13,581 $4,234 31.2%
17000 Destruction of precancer skin growth, 1 growth Office 2023 78 105 $23,918 $4,021 16.8%
11102 Biopsy of related skin growth, first growth Office 2023 44 52 $16,019 $3,445 21.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 30 30 $8,700 $2,307 26.5%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 57 267 $7,430 $1,395 18.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 11 11 $5,021 $1,248 24.9%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 12 14 $1,720 $536.58 31.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 77 113 $23,343 $7,169 30.7%
17110 Destruction of skin growth, 1-14 growths Office 2022 41 55 $20,424 $4,282 21.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 37 43 $12,896 $4,188 32.5%
17000 Destruction of precancer skin growth, 1 growth Office 2022 59 78 $17,454 $2,880 16.5%
11102 Biopsy of related skin growth, first growth Office 2022 34 37 $11,292 $2,415 21.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 26 26 $7,548 $2,024 26.8%
17003 Destruction of precancer skin growth, 2-14 growths Office 2022 45 214 $5,386 $1,100 20.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 106 156 $30,010 $10,260 34.2%
17110 Destruction of up to 14 skin growths Office 2021 81 116 $30,550 $9,668 31.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 50 68 $20,645 $6,188 30.0%
17311 Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) Office 2021 11 12 $18,000 $5,293 29.4%
11102 Tangential biopsy of single skin lesion Office 2021 63 69 $17,680 $4,150 23.5%
17000 Destruction of skin growth Office 2021 84 121 $22,190 $4,129 18.6%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 40 40 $10,640 $3,136 29.5%
11104 Punch biopsy of single skin lesion Office 2021 21 25 $8,119 $2,409 29.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 16 16 $6,520 $1,681 25.8%

About Dr. Monica Rani, MD

Dr. Monica Rani, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2009. The National Provider Identifier (NPI) number assigned to this provider is 1053552240.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Monica Rani, MD has received a total of $44,158 in payments from pharmaceutical and medical device companies, with $143.92 received in 2024. These payments were reported across 393 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($27,590).

As a Medicare-enrolled provider, Rani has provided services to 1,794 Medicare beneficiaries, totaling 3,073 services with total Medicare billing of $140,976. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.

Practice Information

Products in Payments

  • EPIDUO FORTE (Drug) $25,848
  • ORACEA (Drug) $4,686
  • SOOLANTRA (Drug) $3,843
  • Recedo (Drug) $3,109
  • Ecoza (Drug) $1,196
  • Humira (Biological) $572.36
  • EUCRISA (Drug) $527.88
  • Alcortin A (Drug) $308.03
  • DUPIXENT (Drug) $255.29
  • COSENTYX (Biological) $217.11
  • Ecoza Foam (Drug) $200.00
  • STELARA (Biological) $160.83
  • DUPIXENT DUPILUMAB INJECTION (Biological) $153.58
  • Neosalus (Drug) $124.58
  • KERYDIN (Drug) $113.62
  • ENSTILAR (Drug) $113.39
  • Hylatopic (Drug) $106.70
  • Otezla (Drug) $102.55
  • QUINJA (Drug) $101.42
  • Tremfya (Drug) $99.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Chicago